Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Interest & Investment Income: 2013-2017

Historic Interest & Investment Income for Soleno Therapeutics (SLNO) over the last 1 years, with Sep 2017 value amounting to $4,000.

  • Soleno Therapeutics' Interest & Investment Income was N/A to $4,000 in Q3 2017 from the same period last year, while for Sep 2017 it was $8,085, marking a year-over-year change of. This contributed to the annual value of $12.1 million for FY2024, which is 367.49% up from last year.
  • Latest data reveals that Soleno Therapeutics reported Interest & Investment Income of $4,000 as of Q3 2017, which was up 33.33% from $3,000 recorded in Q2 2017.
  • Soleno Therapeutics' Interest & Investment Income's 5-year high stood at $4,000 during Q3 2017, with a 5-year trough of $85 in Q4 2014.
  • Over the past 1 years, Soleno Therapeutics' median Interest & Investment Income value was $3,000 (recorded in 2017), while the average stood at $2,667.
  • Data for Soleno Therapeutics' Interest & Investment Income shows a maximum YoY tumbled of 88.99% (in 2014) over the last 5 years.
  • Soleno Therapeutics' Interest & Investment Income (Quarterly) stood at $772 in 2013, then slumped by 88.99% to $85 in 2014, then reached $4,000 in 2017.
  • Its Interest & Investment Income was $4,000 in Q3 2017, compared to $3,000 in Q2 2017 and $1,000 in Q1 2017.